Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hauser

Showing results (291-300 of 419) with videos related to

Pageof 42
Sort By:
Frontiers in Immunology|April 18, 2022
Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II TrialsTjalf Ziemssen, Douglas L Arnold, Enrique Alvarez, et al.
The Journal of Arthroplasty|December 14, 2001
An electronic database for outcome studies that includes digital radiographsD L Hauser, S J Wessinger, R T Condon, et al.
Neurology|July 22, 2020
Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extensionStephen L Hauser, Ludwig Kappos, Douglas L Arnold, et al.
Genes and Immunity|October 30, 2009
Multiple sclerosis susceptibility alleles in African AmericansB A Johnson, J Wang, E M Taylor, et al.
Human Molecular Genetics|September 10, 2002
Multiple susceptibility loci for multiple sclerosisJonathan L Haines, Yuki Bradford, Melissa E Garcia, et al.
Human Molecular Genetics|July 21, 1998
Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics GroupJ L Haines, H A Terwedow, K Burgess, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2022
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and IIJutta Gärtner, Stephen L Hauser, Amit Bar-Or, et al.
Genes and Immunity|February 24, 2001
Chromosome 17q22-q24 and multiple sclerosis genetic susceptibility. American-French Multiple Sclerosis Genetic GroupB Fontaine, I Cournu, I Arnaud, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2012
Copy number variation in pediatric multiple sclerosisJ P McElroy, L B Krupp, B A Johnson, et al.
Genome Medicine|January 20, 2011
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association dataJoanne H Wang, Derek Pappas, Philip L De Jager, et al.
Pageof 42

Showing results (291-300 of 419) with videos related to

Sort By:
Pageof 42
Frontiers in Immunology|April 18, 2022
Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II TrialsTjalf Ziemssen, Douglas L Arnold, Enrique Alvarez, et al.
The Journal of Arthroplasty|December 14, 2001
An electronic database for outcome studies that includes digital radiographsD L Hauser, S J Wessinger, R T Condon, et al.
Neurology|July 22, 2020
Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extensionStephen L Hauser, Ludwig Kappos, Douglas L Arnold, et al.
Genes and Immunity|October 30, 2009
Multiple sclerosis susceptibility alleles in African AmericansB A Johnson, J Wang, E M Taylor, et al.
Human Molecular Genetics|September 10, 2002
Multiple susceptibility loci for multiple sclerosisJonathan L Haines, Yuki Bradford, Melissa E Garcia, et al.
Human Molecular Genetics|July 21, 1998
Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics GroupJ L Haines, H A Terwedow, K Burgess, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2022
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and IIJutta Gärtner, Stephen L Hauser, Amit Bar-Or, et al.
Genes and Immunity|February 24, 2001
Chromosome 17q22-q24 and multiple sclerosis genetic susceptibility. American-French Multiple Sclerosis Genetic GroupB Fontaine, I Cournu, I Arnaud, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2012
Copy number variation in pediatric multiple sclerosisJ P McElroy, L B Krupp, B A Johnson, et al.
Genome Medicine|January 20, 2011
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association dataJoanne H Wang, Derek Pappas, Philip L De Jager, et al.
Pageof 42